[S-8 POS] Unity Biotechnology, Inc. SEC Filing
Unity Biotechnology filed Post-Effective Amendment No. 1 to terminate the effectiveness of multiple Form S-8 registration statements and to remove from registration all unsold shares of its common stock previously registered under those S-8s. The amendment lists ten prior S-8 filings and the original number of shares registered under each plan, and notes the listed totals do not reflect any interim corporate actions such as stock splits.
Unity Biotechnology ha depositato l'Emendamento Post-Efficace n. 1 per cessare l'efficacia di più dichiarazioni di registrazione in formato Form S-8 e per rimuovere dalla registrazione tutte le azioni ordinarie non vendute precedentemente registrate con tali S-8. L'emendamento elenca dieci depositi S-8 precedenti e il numero originario di azioni registrate per ciascun piano, precisando che i totali indicati non tengono conto di eventuali operazioni societarie intervenute nel frattempo, come frazionamenti azionari.
Unity Biotechnology presentó la Enmienda Post-Efectiva n.º 1 para anular la eficacia de varias declaraciones de registro Form S-8 y para retirar de registro todas las acciones ordinarias no vendidas que previamente se habían registrado bajo esos S-8. La enmienda enumera diez presentaciones S-8 anteriores y el número original de acciones registradas bajo cada plan, y aclara que los totales indicados no reflejan acciones corporativas intermedias como desdoblamientos de acciones.
Unity Biotechnology는 다수의 Form S-8 등록명세서의 효력을 종료하고 해당 S-8에 따라 이전에 등록된 미판매 보통주 전부를 등록에서 말소하기 위해 Post-Effective Amendment No. 1을 제출했습니다. 이 수정안에는 과거 10건의 S-8 제출과 각 플랜별로 최초 등록된 주식 수가 기재되어 있으며, 명시된 총계는 주식분할과 같은 중간 기업행위를 반영하지 않는다고 적시되어 있습니다.
Unity Biotechnology a déposé l'Amendement Post-Effectif n° 1 afin de mettre fin à l'effet de plusieurs déclarations d'enregistrement Form S-8 et de retirer de l'enregistrement toutes les actions ordinaires invendues précédemment enregistrées sous ces S-8. L'amendement énumère dix dépôts S-8 antérieurs et le nombre initial d'actions enregistrées pour chaque plan, en précisant que les totaux indiqués ne tiennent pas compte d'éventuelles opérations d'entreprise intervenues entre-temps, telles que des divisions d'actions.
Unity Biotechnology hat die Post-Effective Amendment Nr. 1 eingereicht, um die Wirksamkeit mehrerer Form S-8-Registrierungserklärungen aufzuheben und alle nicht verkauften Stimmrechte der zuvor unter diesen S-8 registrierten Stammaktien aus der Registrierung zu entfernen. Die Änderung listet zehn frühere S-8-Einreichungen und die ursprünglich für jeden Plan registrierte Aktienanzahl auf und weist darauf hin, dass die angegebenen Summen Zwischenmaßnahmen des Unternehmens wie Aktiensplits nicht berücksichtigen.
- Removed unsold shares from registration under ten S-8 registration statements, clarifying the company’s registered-but-unsold equity status
- Provides a clear list of each S-8 filing and the original number of shares registered under each plan
- None.
Insights
TL;DR: The company formally deregistered unsold employee-plan shares, a routine housekeeping step with limited direct operational impact.
The filing terminates the effectiveness of ten S-8 registration statements and removes unsold shares previously registered for equity incentive and employee stock purchase plans. This action aligns the public record with the company’s current equity plan status and reduces the amount of publicly registered but unsold shares. The filing explicitly lists the original registered share amounts for each S-8 and disclaims adjustments for interim corporate actions.
TL;DR: Administrative deregistration of unsold S-8 shares; no financial results or new transactions disclosed.
The document is a post-effective amendment that removes from registration any and all unsold common stock under ten identified S-8 registration statements ranging in original registered amounts per filing. The filing contains no earnings, financing, or transaction details and contains a caution that listed numbers exclude any corporate actions taken since filing. This is procedural and provides clarity on registered share availability.
Unity Biotechnology ha depositato l'Emendamento Post-Efficace n. 1 per cessare l'efficacia di più dichiarazioni di registrazione in formato Form S-8 e per rimuovere dalla registrazione tutte le azioni ordinarie non vendute precedentemente registrate con tali S-8. L'emendamento elenca dieci depositi S-8 precedenti e il numero originario di azioni registrate per ciascun piano, precisando che i totali indicati non tengono conto di eventuali operazioni societarie intervenute nel frattempo, come frazionamenti azionari.
Unity Biotechnology presentó la Enmienda Post-Efectiva n.º 1 para anular la eficacia de varias declaraciones de registro Form S-8 y para retirar de registro todas las acciones ordinarias no vendidas que previamente se habían registrado bajo esos S-8. La enmienda enumera diez presentaciones S-8 anteriores y el número original de acciones registradas bajo cada plan, y aclara que los totales indicados no reflejan acciones corporativas intermedias como desdoblamientos de acciones.
Unity Biotechnology는 다수의 Form S-8 등록명세서의 효력을 종료하고 해당 S-8에 따라 이전에 등록된 미판매 보통주 전부를 등록에서 말소하기 위해 Post-Effective Amendment No. 1을 제출했습니다. 이 수정안에는 과거 10건의 S-8 제출과 각 플랜별로 최초 등록된 주식 수가 기재되어 있으며, 명시된 총계는 주식분할과 같은 중간 기업행위를 반영하지 않는다고 적시되어 있습니다.
Unity Biotechnology a déposé l'Amendement Post-Effectif n° 1 afin de mettre fin à l'effet de plusieurs déclarations d'enregistrement Form S-8 et de retirer de l'enregistrement toutes les actions ordinaires invendues précédemment enregistrées sous ces S-8. L'amendement énumère dix dépôts S-8 antérieurs et le nombre initial d'actions enregistrées pour chaque plan, en précisant que les totaux indiqués ne tiennent pas compte d'éventuelles opérations d'entreprise intervenues entre-temps, telles que des divisions d'actions.
Unity Biotechnology hat die Post-Effective Amendment Nr. 1 eingereicht, um die Wirksamkeit mehrerer Form S-8-Registrierungserklärungen aufzuheben und alle nicht verkauften Stimmrechte der zuvor unter diesen S-8 registrierten Stammaktien aus der Registrierung zu entfernen. Die Änderung listet zehn frühere S-8-Einreichungen und die ursprünglich für jeden Plan registrierte Aktienanzahl auf und weist darauf hin, dass die angegebenen Summen Zwischenmaßnahmen des Unternehmens wie Aktiensplits nicht berücksichtigen.
FAQ
What did Unity Biotechnology (UBX) file in this S-8 Post-Effective Amendment?
How many S-8 registration statements did Unity deregister in this filing?
Which types of plans were affected by the deregistration in the UBX filing?
Does the filing change the number of shares issued or outstanding?
Are there any financial results or transactions disclosed in this amendment?
